sglt2 inhibitors vs glp 1 Perspectives in weight control in diabetes – and GLP-1–glucagon dual agonism Cardiovascular benefits of SGLT2 inhibitors

Although short-term trials have shown promising results, as well as the obvious results that some people are sharing, the long-term data is needed to fully understand the potential risks

L., Brnden, A., Karstoft, K., et al

The GLP-1 injections mimic the action of natural GLP-1, helping to improve blood sugar control and promote weight loss

Risk factors for HFpEF include obesity and type 2 diabetes

Personalized GLP-1 is a custom-formulated version of the GLP-1 receptor agonist designed regulate blood sugar control resulting to weight loss management

In addition to secreted ATP from type II cells, type III cells get depolarized in response to acids [41]